Cancer and Leukemia Group B: RPCI/SUNYAB

癌症和白血病 B 组：RPCI/SUNYAB

基本信息

批准号：
8455695
负责人：
ELLIS G LEVINE
金额：
$ 17.54万
依托单位：
ROSWELL PARK CANCER INSTITUTE CORP
依托单位国家：
美国
项目类别：
财政年份：
1993
资助国家：
美国
起止时间：
1993-04-15 至 2014-02-28
项目状态：
已结题

项目摘要

Roswell Park Cancer Institute (RPCI) is requesting support to continue its participation in the Cancer and Leukemia Group B (CALGB). The goals of our participation in CALGB include the following: (1) to continue our strong contribution to the scientific agenda of the Group, (2) to continue our performance of pilot activity at the local level that can be considered for Group adaptation, (3) to continue our administrative support for the efficient functioning of the Group, (4) to sustain accrual in order to allow the rapid accumulation of clinical data and experience through the cooperative group process, and (5) to continue to provide data of high quality in a timely manner. Over the last grant period, we have contributed substantially to the scientific, administrative, core, and publication activities of the CALGB. More specifically, 6 RPCI members serve or have served as chairs or vice chairs of scientific committees; 16 serve or have served as members on scientific committees; 12 serve or have served as study chairs or vice-chairs on 22 protocols; 3 have protocols under consideration; 9 provide or have provided core services to the Group; and 5 have performed pilot studies that have led to the development of CALGB protocols. RPCI members have contributed to 71 publications and given 58 education sessions. Furthermore, 8 members have or have had administrative roles in the Group. RPCI also represents an ongoing resource of ideas for future CALGB science; RPCI has a vigorous Phase I/I I program with many protocols potentially exportable to the Group. CALGB accrual by RPCI is customarily between 200-250 credits/year. Data quality and timeliness of submission has met Group standards. The campus spans 25 acres in downtown Buffalo and consists of 10 research and clinical buildings with approximately one million square feet of space. Statistics for fiscal year 2006-2007 include 6805 new cancer cases, 4215 hospital admissions, and 161,869 outpatient visits from patients in 36 states and 5 foreign countries. Both the inpatient and the outpatient centers are located in a spacious facility that opened in 1998.

罗斯威尔公园癌症研究所（RPCI）要求支持继续参与癌症和白血病B（CALGB）。我们参与CALGB的目标包括以下内容：（1）继续我们对小组的科学议程的巨大贡献，（2）继续我们的飞行员活动表现在可以考虑进行小组适应的地方，（3）继续我们的行政支持该组的有效功能，（4）维持应计，以便快速积累临床通过合作小组流程进行数据和经验，（5）继续提供高的数据及时的质量。在上一个赠款期间，我们为科学，大力做出了贡献 CALB的行政，核心和出版活动。更具体地说，有6名RPCI成员服务或曾担任科学委员会主席或副主席； 16或曾担任成员科学委员会；在22个方案中担任研究椅或副主席的12个； 3有正在考虑的协议； 9向小组提供或提供核心服务；和5进行了导致制定CALB方案的试点研究。 RPCI成员已为71个出版物并进行了58次教育课程。此外，有8位成员已经或有管理在小组中的角色。 RPCI还代表了未来Calgb科学的持续思想资源； RPCI有一个有力的I/I I计划，该计划具有许多可能出口到该组的协议。 CALGB应计 RPCI通常在200-250个学分之间。数据质量和提交的及时性达到了小组标准。校园占地25英亩，位于布法罗市中心，包括10个研究和临床大约一百万平方英尺空间的建筑物。 2006-2007财政年度的统计数据包括 6805例新的癌症病例，4215例医院入院和161,869例患者的门诊就诊和5个外国。住院和门诊中心都位于宽敞的设施中于1998年开放。

项目成果

期刊论文数量（11）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129.

具有 V 型 PML-RARα 亚型的成人 APL 患者的分子分析和临床结果：来自组间方案 0129 的结果。

DOI：
发表时间：
2000
期刊：
Blood
影响因子：
20.3
作者：
Slack,JL;Willman,CL;Andersen,JW;Li,YP;Viswanatha,DS;Bloomfield,CD;Tallman,MS;Gallagher,RE
通讯作者：
Gallagher,RE

Flow cytometry in node-positive breast cancer: cancer and leukemia group B protocol 8869.

流式细胞术在淋巴结阳性乳腺癌中的应用：癌症和白血病 B 组方案 8869。

DOI：
10.1002/cyto.990220406
发表时间：
1995
期刊：
Cytometry
影响因子：
0
作者：
Kute,TE;Quadri,Y;Muss,H;Zbieranski,N;Cirrincione,C;Berry,DA;Barcos,M;Thor,AP;Liu,E;Koerner,F
通讯作者：
Koerner,F

Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.

重组 α-2b-干扰素治疗先前未经治疗的毛细胞白血病：癌症和白血病 B 组研究的长期随访结果。